Tech Company Financing Transactions
BioDirection Funding Round
Shepherd Kaplan Krochuk and private investors participated in a $18 million Series C funding round for BioDirection. This VC investment round closed on 7/2/2020.
Transaction Overview
Company Name
Announced On
7/2/2020
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series C
Investors
Shepherd Kaplan Krochuk (Lead Investor)
Proceeds Purpose
These funds will drive final product validation, scale-up of the NanoDx System manufacturing, and initial product introductions into the US and European markets this year.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
144 Turnpike Rd. 110
Southborough, MA 01772
USA
Southborough, MA 01772
USA
Phone
Website
Email Address
Overview
NanoDx Inc. is a privately held medical device company developing novel and rapid point-of-care technologies for the objective diagnosis and management of concussion and other traumatic brain injury (TBI).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
James Wylie
Chief Executive Officer
Sharad Joshi
Chief Scientific Officer
Sergey Dryga
VP - Human Resources
Kelly Downs
VP - Marketing
Tony Tremaglio
VP - Sales
Michael Sampson
VP - Sales
Marco Witteveen
Browse more venture capital transactions:
Prev: 7/1/2020: Emissary venture capital transaction
Next: 7/2/2020: Amylyx Pharmaceuticals venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs